Average Insider

Where insiders trade, we follow

BridgeBio Pharma, Inc. ($BBIO)
Accession: 0001470831-26-000836
Aug 18, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$46.81
Current$82.9477.5% above low, 22.5% below high
52W High$93.42

Filing Information

Accession Number0001470831-26-000836
Form Type4
Filing DateAug 18, 2026
DocumentView SEC Filing
Transactions
9
Total Shares
178,671
Total Value
$2,893,886.82

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Kumar Neil
Director
Common Stock
โ€”Aug 16, 2026Exercise/Conversion33,544โ€”โ€”276,871Directโ€”View Details
Kumar Neil
Director
Common Stock
โ€”Aug 16, 2026Exercise/Conversion19,599โ€”โ€”296,470Directโ€”View Details
Kumar Neil
Director
Common Stock
โ€”Aug 16, 2026Exercise/Conversion11,554โ€”โ€”308,024Directโ€”View Details
Kumar Neil
Director
Common Stock
โ€”Aug 16, 2026Exercise/Conversion6,520โ€”โ€”314,544Directโ€”View Details
Kumar Neil
Director
Common Stock
โ€”Aug 16, 2026Tax Withholding36,237$79.86$2,893,886.82278,307Directโ€”View Details
Kumar Neil
Director
Restricted Stock Units
(Common Stock)
DerivativeAug 16, 2026Exercise/Conversion33,544$0.00$0.0067,088Directโ€”View Details
Kumar Neil
Director
Restricted Stock Units
(Common Stock)
DerivativeAug 16, 2026Exercise/Conversion19,599$0.00$0.00117,596Directโ€”View Details
Kumar Neil
Director
Restricted Stock Units
(Common Stock)
DerivativeAug 16, 2026Exercise/Conversion11,554$0.00$0.00115,538Directโ€”View Details
Kumar Neil
Director
Restricted Stock Units
(Common Stock)
DerivativeAug 16, 2026Exercise/Conversion6,520$0.00$0.0091,274Directโ€”View Details
Version: v26.7.3